finasteride 5mg
Selected indexed studies
- The finasteride prostate cancer prevention trial (PCPT)--what have we learned? (Eur J Cancer, 2005) [PMID:16061372]
- Development of Stable and Simple Finasteride 333-μg/mL Suspensions that Minimize Occupational Exposure. (Int J Pharm Compd, 2020) [PMID:33217743]
- Comparison of finasteride versus flutamide in the treatment of hirsutism. (Eur J Endocrinol, 1999) [PMID:10526249]
_Worker-drafted node — pending editorial review._
Connections
finasteride 5mg is a side effect of
Sources
- The finasteride prostate cancer prevention trial (PCPT)--what have we learned? (2005) pubmed
- Development of Stable and Simple Finasteride 333-μg/mL Suspensions that Minimize Occupational Exposure. (2020) pubmed
- Comparison of finasteride versus flutamide in the treatment of hirsutism. (1999) pubmed
- Tissue Effects in a Randomized Controlled Trial of Short-term Finasteride in Early Prostate Cancer. (2016) pubmed
- Effect of finasteride on serum levels of androstenedione, testosterone and their 5α-reduced metabolites in men at risk for prostate cancer. (2013) pubmed
- The effect of St. John's wort on the pharmacokinetics, metabolism and biliary excretion of finasteride and its metabolites in healthy men. (2009) pubmed
- Spironolactone versus placebo or in combination with steroids for hirsutism and/or acne. (2003) pubmed
- Platelet-rich plasma with low dose oral minoxidil (1.25mg versus 2.5mg) along with trichoscopic pre- and post-treatment evaluation. (2021) pubmed
- Combination therapy with rofecoxib and finasteride in the treatment of men with lower urinary tract symptoms (LUTS) and benign prostatic hyperplasia (BPH). (2005) pubmed
- The effect of finasteride on spermatogenesis of Mesocricetus auratus. (2008) pubmed